METRONIDAZOLE IN PLASTIC CONTAINER Drug Patent Profile
✉ Email this page to a colleague
When do Metronidazole In Plastic Container patents expire, and what generic alternatives are available?
Metronidazole In Plastic Container is a drug marketed by Amneal, Baxter Hlthcare Corp, Gland Pharma Ltd, Hospira, Inforlife, and Rising. and is included in six NDAs.
The generic ingredient in METRONIDAZOLE IN PLASTIC CONTAINER is metronidazole. There are eighteen drug master file entries for this compound. Seventy-one suppliers are listed for this compound. Additional details are available on the metronidazole profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Metronidazole In Plastic Container
A generic version of METRONIDAZOLE IN PLASTIC CONTAINER was approved as metronidazole by TEVA PHARMS USA on November 6th, 1984.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for METRONIDAZOLE IN PLASTIC CONTAINER?
- What are the global sales for METRONIDAZOLE IN PLASTIC CONTAINER?
- What is Average Wholesale Price for METRONIDAZOLE IN PLASTIC CONTAINER?
Summary for METRONIDAZOLE IN PLASTIC CONTAINER
US Patents: | 0 |
Applicants: | 6 |
NDAs: | 6 |
Finished Product Suppliers / Packagers: | 6 |
Raw Ingredient (Bulk) Api Vendors: | 172 |
Clinical Trials: | 526 |
Patent Applications: | 2,430 |
Formulation / Manufacturing: | see details |
DailyMed Link: | METRONIDAZOLE IN PLASTIC CONTAINER at DailyMed |
![METRONIDAZOLE IN PLASTIC CONTAINER drug patent expirations Drug patent expirations by year for METRONIDAZOLE IN PLASTIC CONTAINER](/p/graph/s/t/METRONIDAZOLE_IN_PLASTIC_CONTAINER-patent-expirations.png)
Recent Clinical Trials for METRONIDAZOLE IN PLASTIC CONTAINER
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Hospital Universitario Evangelico de Curitiba | Phase 3 |
National Dental PBRN | Phase 3 |
Rutgers, The State University of New Jersey | Phase 3 |
Pharmacology for METRONIDAZOLE IN PLASTIC CONTAINER
Drug Class | Nitroimidazole Antimicrobial |